Autoimmune Diseases  >>  placulumab (CEP-37247)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
placulumab (CEP-37247) / Teva
NCT00928317 / 2008-006930-92: Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Terminated
2
13
US, Europe, RoW
ART621, Placebo
Arana Therapeutics Ltd
Rheumatoid Arthritis
11/09
12/09
NCT00854685: Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Completed
2
27
RoW
ART621, Placebo
Arana Therapeutics Ltd, Trident Clinical Research Pty Ltd
Rheumatoid Arthritis
12/09
01/10

Download Options